Processing of the Epstein-Barr virus-encoded latent membrane protein p63/LMP
- PMID: 2153246
- PMCID: PMC249178
- DOI: 10.1128/JVI.64.2.829-837.1990
Processing of the Epstein-Barr virus-encoded latent membrane protein p63/LMP
Abstract
We have analyzed the processing of the Epstein-Barr virus-encoded latent membrane protein (p63/LMP) in lymphoblastoid cell lines, Burkitt's lymphoma cell lines, and rodent fibroblasts transfected with the p63/LMP gene. Pulse-chase analysis by immunoprecipitation, under denaturing conditions, reveals a half-life of 2 h. This is due to turnover in the plasma membrane with cleavage of the protein, resulting in a 25,000-molecular-weight (p25) fragment derived from the carboxy-terminal portion of LMP. This fragment is rich in proline and acidic amino acids and sheds into the cytoplasm, where it appears to accumulate, being present in a six- to sevenfold molar excess over p63/LMP in immunoprecipitation analyses. p25 is, like p63/LMP, also phosphorylated (pp25) on serine and threonine residues, in the same ratio and to approximately the same extent as the intact p63/LMP molecule. Amino acid sequence analysis and carboxy-terminal labeling suggest that p25 is derived through a single cleavage adjacent to the sequence LGAPGGGPDNGPQDPD.
Similar articles
-
Biochemical, genetic, and functional analyses of the phosphorylation sites on the Epstein-Barr virus-encoded oncogenic latent membrane protein LMP-1.J Virol. 1993 May;67(5):2637-45. doi: 10.1128/JVI.67.5.2637-2645.1993. J Virol. 1993. PMID: 8386269 Free PMC article.
-
Posttranslational processing of the Epstein-Barr virus-encoded p63/LMP protein.J Virol. 1987 Jul;61(7):2100-8. doi: 10.1128/JVI.61.7.2100-2108.1987. J Virol. 1987. PMID: 3035211 Free PMC article.
-
Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.J Virol. 1990 May;64(5):2126-34. doi: 10.1128/JVI.64.5.2126-2134.1990. J Virol. 1990. PMID: 2157875 Free PMC article.
-
[Sequence analysis of the carboxy terminal of the Epstein-Barr virus LMP-1 oncogene in Epstein-Barr virus associated disorders].Nihon Rinsho. 1997 Feb;55(2):467-72. Nihon Rinsho. 1997. PMID: 9046842 Review. Japanese.
-
Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?Adv Cancer Res. 2000;79:175-200. doi: 10.1016/s0065-230x(00)79006-3. Adv Cancer Res. 2000. PMID: 10818681 Review.
Cited by
-
Functional diversity: update of the posttranslational modification of Epstein-Barr virus coding proteins.Cell Mol Life Sci. 2022 Nov 14;79(12):590. doi: 10.1007/s00018-022-04561-2. Cell Mol Life Sci. 2022. PMID: 36376593 Free PMC article. Review.
-
Biochemical, genetic, and functional analyses of the phosphorylation sites on the Epstein-Barr virus-encoded oncogenic latent membrane protein LMP-1.J Virol. 1993 May;67(5):2637-45. doi: 10.1128/JVI.67.5.2637-2645.1993. J Virol. 1993. PMID: 8386269 Free PMC article.
-
E3 Ubiquitin Ligases in Gammaherpesviruses and HIV: A Review of Virus Adaptation and Exploitation.Viruses. 2023 Sep 15;15(9):1935. doi: 10.3390/v15091935. Viruses. 2023. PMID: 37766341 Free PMC article. Review.
-
Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus.J Virol. 1995 May;69(5):2968-76. doi: 10.1128/JVI.69.5.2968-2976.1995. J Virol. 1995. PMID: 7707523 Free PMC article.
-
Characterization of the CD48 gene demonstrates a positive element that is specific to Epstein-Barr virus-immortalized B-cell lines and contains an essential NF-kappa B site.J Virol. 1995 Feb;69(2):871-81. doi: 10.1128/JVI.69.2.871-881.1995. J Virol. 1995. PMID: 7815555 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources